longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Wantai Biological

603392

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Wantai Biological(603392) the Revenue is 525.12 M (+18.55%);the EBIT is -120.93 M (+4.3%);the EPS is -0.0753 (-7.19%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.53B18.55%
----
----
EBIT
-0.12B4.30%
----
----
EPS
-0.07537.19%
----
----

Revenue

ActualEstimateUnit: CNY
qf

EBIT

ActualEstimateUnit: CNY
qf

Net income

ActualEstimateUnit: CNY
qf

EPS

ActualEstimateUnit: CNY
qf